0001387131-16-005874.txt : 20160621 0001387131-16-005874.hdr.sgml : 20160621 20160621124811 ACCESSION NUMBER: 0001387131-16-005874 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160620 FILED AS OF DATE: 20160621 DATE AS OF CHANGE: 20160621 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ohr Pharmaceutical Inc CENTRAL INDEX KEY: 0001173281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465622433 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 800 THIRD AVENUE STREET 2: 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 682-8452 MAIL ADDRESS: STREET 1: 800 THIRD AVENUE STREET 2: 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: BBM HOLDINGS, INC. DATE OF NAME CHANGE: 20070402 FORMER COMPANY: FORMER CONFORMED NAME: PRIME RESOURCE INC DATE OF NAME CHANGE: 20020513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Slakter Jason Scott CENTRAL INDEX KEY: 0001630109 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35963 FILM NUMBER: 161723857 MAIL ADDRESS: STREET 1: 57 MEADOW WOODS ROAD CITY: GREAT NECK STATE: NY ZIP: 11020 4 1 slakter-form4_062016.xml OWNERSHIP DOCUMENT X0306 4 2016-06-20 0 0001173281 Ohr Pharmaceutical Inc OHRP 0001630109 Slakter Jason Scott C/O OHR PHARMACEUTICAL INC. 800 THIRD AVE, 11TH FLOOR NEW YORK NY 10022 1 1 0 0 Chief Executive Officer Common Stock, par value $0.0001 per share 2016-06-20 4 P 0 1700 2.89 A 917954 D Common Stock, par value $0.0001 per share 2016-06-20 4 P 0 85 2.88 A 918039 D Common Stock, par value $0.0001 per share 2016-06-20 4 P 0 1019 2.87 A 919058 D Common Stock, par value $0.0001 per share 2016-06-20 4 P 0 5431 2.84 A 924489 D Common Stock, par value $0.0001 per share 2016-06-20 4 P 0 1 2.83 A 924490 D Common Stock, par value $0.0001 per share 2016-06-20 4 P 0 550 2.71 A 925040 D Common Stock, par value $0.0001 per share 697865 I By SKS Ocular I LLC SKS Ocular I LLC directly owns the shares of Common Stock. On May 30, 2014, the Issuer completed an ophthalmology assets acquisition of SKS Ocular LLC and SKS Ocular I LLC. Pursuant to the acquisition agreement, among other things, SKS Ocular I LLC is eligible to receive additional shares of Common Stock in three contingent milestone payments. Milestone 1 has been met December 15, 2015, the Issuer issued 497,859 shares of Common Stock to SKS Ocular I LLC. The Reporting Person has investment and voting power with respect to the Common Stock held by SKS Ocular 1 LLC. Therefore, the Reporting Person may be deemed to beneficially own the shares of Common Stock beneficially owned by SKS Ocular 1 LLC. The Reporting Person disclaims any beneficial ownership of the Common Stock directly owed by SKS Ocular I LLC except to the extent of his pecuniary interest therein. /s/ Jason Scott Slakter 2016-06-21